RecruitingPhase 3NCT06091202

Tele-Collaborative Outreach to Rural Patients With Chronic Pain

Tele-Collaborative Outreach to Rural Patients With Chronic Pain: The CORPs Trial


Sponsor

Oregon Health and Science University

Enrollment

608 participants

Start Date

Jul 11, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized controlled trial comparing the effectiveness of a remotely delivered collaborative care intervention for chronic pain versus a minimally enhanced control group. The specific aims of the study are: (1) compare the effectiveness of tele-collaborative pain care vs. minimally enhanced usual care to improve pain interference over 12 months of follow-up, and (2) oversample women and rural veterans of minoritized race/ethnicity to test heterogeneity of treatment effects across birth sex and race/ethnicity.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • U.S. Veteran
  • Rural Residence based on Rural Urban Commuting Area codes
  • High Impact Chronic pain, determined through a phone screening
  • Access to landline or cell phone
  • English Speaking

Exclusion Criteria6

  • Cognitive impairment that would impact participation in the study
  • Plans to move in the next 3 months
  • Surgery in the past 3 months
  • In long-term inpatient or hospice care
  • Terminal illness (defined as life expectancy of less than 12 months)
  • Active participation in another pain intervention study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCORPs Intervention

Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference. After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months. A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.

BEHAVIORALMinimally Enhanced Usual Care (MEUC)

Participants will be randomly assigned to the intervention or to the comparator arm. The follow-up period is 12 months. The primary outcome is a change in pain interference. After the baseline assessment, participants will complete a masked telephone assessments with research staff at 3-, 6-, 9-, and 12-months. A subset of individuals may be invited to participate in a qualitative interview at 12-month follow-up.


Locations(4)

VA Minneapolis Health Care System

Minneapolis, Minnesota, United States

VA Portland Health Care System

Portland, Oregon, United States

VA Tennessee Valley Health Care System

Nashville, Tennessee, United States

VA North Texas Health Care System

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06091202


Related Trials